These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11227130)

  • 21. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational screening of the parkin gene among South Indians with early onset Parkinson's disease.
    Madegowda RH; Kishore A; Anand A
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1588-90. PubMed ID: 16227559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease.
    Maraganore DM; Farrer MJ; Lesnick TG; de Andrade M; Bower JH; Hernandez D; Hardy JA; Rocca WA
    Mov Disord; 2003 Nov; 18(11):1233-9. PubMed ID: 14639662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alpha-synuclein gene and Parkinson disease in a Chinese population.
    Chan DK; Mellick G; Cai H; Wang XL; Ng PW; Pang CP; Woo J; Kay R
    Arch Neurol; 2000 Apr; 57(4):501-3. PubMed ID: 10768624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-synuclein mRNA expression in sporadic Parkinson's disease.
    Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y
    Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.
    Neystat M; Lynch T; Przedborski S; Kholodilov N; Rzhetskaya M; Burke RE
    Mov Disord; 1999 May; 14(3):417-22. PubMed ID: 10348463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients.
    Muñoz E; Oliva R; Obach V; Martí MJ; Pastor P; Ballesta F; Tolosa E
    Neurosci Lett; 1997 Oct; 235(1-2):57-60. PubMed ID: 9389595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
    Berg D; Niwar M; Maass S; Zimprich A; Möller JC; Wuellner U; Schmitz-Hübsch T; Klein C; Tan EK; Schöls L; Marsh L; Dawson TM; Janetzky B; Müller T; Woitalla D; Kostic V; Pramstaller PP; Oertel WH; Bauer P; Krueger R; Gasser T; Riess O
    Mov Disord; 2005 Sep; 20(9):1191-4. PubMed ID: 15895422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No pathogenic mutations in the beta-synuclein gene in Parkinson's disease.
    Lincoln S; Crook R; Chartier-Harlin MC; Gwinn-Hardy K; Baker M; Mouroux V; Richard F; Becquet E; Amouyel P; Destée A; Hardy J; Farrer M
    Neurosci Lett; 1999 Jul; 269(2):107-9. PubMed ID: 10430516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of the G209A mutation in the alpha-synuclein gene in British families with Parkinson's disease.
    Bennett P; Nicholl DJ
    Neurology; 1998 Apr; 50(4):1183. PubMed ID: 9566424
    [No Abstract]   [Full Text] [Related]  

  • 31. Parkin mutations in familial and sporadic Parkinson's disease among Indians.
    Chaudhary S; Behari M; Dihana M; Swaminath PV; Govindappa ST; Jayaram S; Goyal V; Maitra A; Muthane UB; Juyal RC; Thelma BK
    Parkinsonism Relat Disord; 2006 May; 12(4):239-45. PubMed ID: 16500134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J; Uversky VN; Fink AL
    Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.
    Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH
    Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low frequency of alpha-synuclein mutations in familial Parkinson's disease.
    Farrer M; Wavrant-De Vrieze F; Crook R; Boles L; Perez-Tur J; Hardy J; Johnson WG; Steele J; Maraganore D; Gwinn K; Lynch T
    Ann Neurol; 1998 Mar; 43(3):394-7. PubMed ID: 9506559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease.
    Hope AD; Myhre R; Kachergus J; Lincoln S; Bisceglio G; Hulihan M; Farrer MJ
    Neurosci Lett; 2004 Aug; 367(1):97-100. PubMed ID: 15308306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival duration of Parkinson's disease patients living in Greece who carry the G209A alpha-synuclein mutation.
    Papapetropoulos S; Paschalis C; Ellul J; Papapetropoulos T; Athanassiadou A
    Mov Disord; 2002 Jul; 17(4):847-8. PubMed ID: 12210894
    [No Abstract]   [Full Text] [Related]  

  • 37. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
    Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S; Arai H; Matsushita S; Matsui T; Kimpara T; Takeda A; Shirakura K
    Exp Neurol; 1998 Sep; 153(1):164-6. PubMed ID: 9743579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.
    Papapetropoulos S; Paschalis C; Athanassiadou A; Papadimitriou A; Ellul J; Polymeropoulos MH; Papapetropoulos T
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):662-5. PubMed ID: 11309462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.